Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 04-2012 | 03-2012 | 01-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,308 | 413 | -2,308 | 392 | -9,015 |
| Depreciation Amortization | 301 | 160 | 151 | 577 | 630 |
| Income taxes - deferred | N/A | 234 | N/A | 436 | N/A |
| Accounts receivable | N/A | -719 | N/A | -655 | N/A |
| Accounts payable and accrued liabilities | 256 | -581 | 775 | -116 | 424 |
| Other Working Capital | -325 | -1,171 | 305 | -1,866 | 268 |
| Other Operating Activity | -402 | 1,691 | -588 | 2,756 | -2,403 |
| Operating Cash Flow | $-5,478 | $27 | $-1,665 | $1,524 | $-10,096 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,208 | -115 | -1,552 | -1,068 | -1,802 |
| Purchase Of Investment | -2,057 | N/A | N/A | N/A | -10,201 |
| Sale Of Investment | 7,216 | N/A | 3,189 | N/A | 20,896 |
| Purchase Sale Intangibles | -28 | N/A | N/A | N/A | -234 |
| Other Investing Activity | -21 | 0 | 6 | 0 | -238 |
| Investing Cash Flow | $1,930 | $-115 | $1,643 | $-1,068 | $8,655 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,640 | 120 | 582 | 799 | 1,695 |
| Debt Repayment | -25 | -189 | -13 | -1,260 | -71 |
| Financing Cash Flow | $2,615 | $-69 | $569 | $-461 | $1,624 |
| Beginning Cash Position | 3,103 | 157 | 3,103 | 162 | 2,920 |
| End Cash Position | 2,170 | N/A | 3,650 | 157 | 3,103 |
| Net Cash Flow | $-933 | $-157 | $547 | $-5 | $183 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,478 | 27 | -1,665 | 1,524 | -10,096 |
| Capital Expenditure | -3,208 | -115 | -1,552 | -1,068 | -1,802 |
| Free Cash Flow | -8,686 | -88 | -3,217 | 456 | -11,898 |